ID810B - KRISTAL BENTUK ε DARI 2-(4-(2-FUROIL)-(2-PIPERAZIN)-1-IL)-4-AMINO-6,7-DIMETOKSIQUINAZOLIN HIDROKLORIDA ANHIDRAT DAN PROSES UNTUK PEMBUATANNYA - Google Patents
KRISTAL BENTUK ε DARI 2-(4-(2-FUROIL)-(2-PIPERAZIN)-1-IL)-4-AMINO-6,7-DIMETOKSIQUINAZOLIN HIDROKLORIDA ANHIDRAT DAN PROSES UNTUK PEMBUATANNYAInfo
- Publication number
- ID810B ID810B IDP16787A ID870167A ID810B ID 810 B ID810 B ID 810B ID P16787 A IDP16787 A ID P16787A ID 870167 A ID870167 A ID 870167A ID 810 B ID810 B ID 810B
- Authority
- ID
- Indonesia
- Prior art keywords
- hydroxloride
- dimetocysiquinazoline
- furoil
- anhydrates
- piperazin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP86103925A EP0237608B1 (de) | 1986-03-21 | 1986-03-21 | Kristalline, wasserfreie Sigma -Form von 2-[4-(2-Furoyl-(2-piperazin)-1-yl]-4-amino-6,7-dimethoxychinazolinhydrochlorid und Verfahren zu ihrer Herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID810B true ID810B (id) | 1996-07-15 |
Family
ID=8194990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDP16787A ID810B (id) | 1986-03-21 | 1987-02-19 | KRISTAL BENTUK ε DARI 2-(4-(2-FUROIL)-(2-PIPERAZIN)-1-IL)-4-AMINO-6,7-DIMETOKSIQUINAZOLIN HIDROKLORIDA ANHIDRAT DAN PROSES UNTUK PEMBUATANNYA |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4816455B1 (id) |
| EP (1) | EP0237608B1 (id) |
| JP (1) | JPH0662615B2 (id) |
| KR (1) | KR870008875A (id) |
| AR (1) | AR242384A1 (id) |
| AT (1) | ATE72244T1 (id) |
| AU (1) | AU586318B2 (id) |
| CA (1) | CA1240999A (id) |
| DE (1) | DE3683760D1 (id) |
| DK (1) | DK173283B1 (id) |
| ES (1) | ES2009486A6 (id) |
| GR (1) | GR870429B (id) |
| HU (1) | HU200176B (id) |
| ID (1) | ID810B (id) |
| IE (1) | IE59913B1 (id) |
| IL (1) | IL81841A (id) |
| NZ (1) | NZ219644A (id) |
| PT (1) | PT84496B (id) |
| ZA (1) | ZA87966B (id) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5412095A (en) * | 1993-04-29 | 1995-05-02 | Abbott Laboratories | Terazosin monohydrochloride and processes and intermediate for its production |
| US5504207A (en) * | 1994-10-18 | 1996-04-02 | Abbott Laboratories | Process and intermediate for the preparation of terazosin hydrochloride dihydrate |
| EP0794178A4 (en) * | 1994-11-25 | 1998-02-25 | Nippon Chemiphar Co | CHINAZOLIN DERIVATIVES |
| US5587377A (en) * | 1995-10-24 | 1996-12-24 | Invamed, Inc. | Terazosin crystalline polymorph and pharmaceutical compositions thereof |
| DE59611417D1 (de) * | 1996-12-20 | 2007-03-29 | Heumann Pharma Gmbh & Co | Neue polymorphe Form von Doxazosinmesylat (Form III) |
| EP0849265A1 (de) * | 1996-12-20 | 1998-06-24 | HEUMANN PHARMA GmbH | Neue polymorphe Form von Doxazosin-Mesylat (Form II) |
| EP0849264A1 (de) * | 1996-12-20 | 1998-06-24 | HEUMANN PHARMA GmbH | Neue polymorphe Form von doxazosinmesylat (Form I) |
| CA2566652C (en) | 1998-06-19 | 2008-10-21 | Teijin Limited | Polymorphic modifications of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazole-carboxylic acid and processes for the preparation thereof |
| US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| CL2004001034A1 (es) | 2003-05-14 | 2005-03-28 | Teijin Pharma Ltd | Formas cristalinas de acido 4-(1-((,etilbenzotiofen-3-il)me til)benzimidazol-2-iltio)butanoico; procedimiento de preparacion de las formas cristalinas; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias, alergicas, r |
| US7501426B2 (en) | 2004-02-18 | 2009-03-10 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
| DE102004054054A1 (de) | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
| JPWO2006052026A1 (ja) * | 2004-11-12 | 2008-05-29 | 帝人ファーマ株式会社 | ベンズイミダゾール誘導体の酸性塩及びその結晶 |
| DE102005035891A1 (de) | 2005-07-30 | 2007-02-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
| EP2540725A1 (de) | 2006-05-04 | 2013-01-02 | Boehringer Ingelheim International GmbH | Polymorphe von 1-((4-Methyl-chinazolin-2-yl)methyl)-3-methyl-7-(2-butin-1-yl)-8-(3-(R)-amino-piperidin-1-yl)xanthin |
| EP1852108A1 (en) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
| PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
| WO2009024542A2 (en) * | 2007-08-17 | 2009-02-26 | Boehringer Ingelheim International Gmbh | Purin derivatives for use in the treatment of fab-related diseases |
| PE20091730A1 (es) | 2008-04-03 | 2009-12-10 | Boehringer Ingelheim Int | Formulaciones que comprenden un inhibidor de dpp4 |
| PE20100156A1 (es) * | 2008-06-03 | 2010-02-23 | Boehringer Ingelheim Int | Tratamiento de nafld |
| UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
| BRPI0916997A2 (pt) | 2008-08-06 | 2020-12-15 | Boehringer Ingelheim International Gmbh | Inibidor de dpp-4 e seu uso |
| NZ604091A (en) * | 2008-08-15 | 2014-08-29 | Boehringer Ingelheim Int | Purin derivatives for use in the treatment of fab-related diseases |
| CN102149407A (zh) | 2008-09-10 | 2011-08-10 | 贝林格尔.英格海姆国际有限公司 | 治疗糖尿病和相关病症的组合疗法 |
| US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
| CN102256976A (zh) | 2008-12-23 | 2011-11-23 | 贝林格尔.英格海姆国际有限公司 | 有机化合物的盐形式 |
| AR074990A1 (es) | 2009-01-07 | 2011-03-02 | Boehringer Ingelheim Int | Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina |
| KR20240090632A (ko) | 2009-11-27 | 2024-06-21 | 베링거 인겔하임 인터내셔날 게엠베하 | 리나글립틴과 같은 ｄｐｐ－ｉｖ 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료 |
| CN102946875A (zh) | 2010-05-05 | 2013-02-27 | 贝林格尔.英格海姆国际有限公司 | 组合疗法 |
| WO2011161161A1 (en) | 2010-06-24 | 2011-12-29 | Boehringer Ingelheim International Gmbh | Diabetes therapy |
| AR083878A1 (es) | 2010-11-15 | 2013-03-27 | Boehringer Ingelheim Int | Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento |
| US8883800B2 (en) | 2011-07-15 | 2014-11-11 | Boehringer Ingelheim International Gmbh | Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions |
| US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
| JP6218811B2 (ja) | 2012-05-14 | 2017-10-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｓｉｒｓ及び／又は敗血症の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体 |
| JP6224084B2 (ja) | 2012-05-14 | 2017-11-01 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 糸球体上皮細胞関連障害及び／又はネフローゼ症候群の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体 |
| WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
| EP3110449B1 (en) | 2014-02-28 | 2023-06-28 | Boehringer Ingelheim International GmbH | Medical use of a dpp-4 inhibitor |
| CN109310697A (zh) | 2016-06-10 | 2019-02-05 | 勃林格殷格翰国际有限公司 | 利格列汀和二甲双胍的组合 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3511836A (en) | 1967-12-13 | 1970-05-12 | Pfizer & Co C | 2,4,6,7-tetra substituted quinazolines |
| US4026894A (en) * | 1975-10-14 | 1977-05-31 | Abbott Laboratories | Antihypertensive agents |
| US4092315A (en) * | 1976-03-01 | 1978-05-30 | Pfizer Inc. | Novel crystalline forms of prazosin hydrochloride |
| GB1591490A (en) * | 1977-08-04 | 1981-06-24 | Abbott Lab | 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate |
| DE3375395D1 (en) * | 1983-11-22 | 1988-02-25 | Heumann Ludwig & Co Gmbh | Process for the preparation of 4-amino-6,7-dimethoxy-2-(4-(furoyl-2)-piperazin-1-yl)-quinazoline and its physiologically acceptable salt |
| FI79107C (fi) * | 1984-06-25 | 1989-11-10 | Orion Yhtymae Oy | Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid. |
-
1986
- 1986-03-21 EP EP86103925A patent/EP0237608B1/de not_active Expired - Lifetime
- 1986-03-21 DE DE8686103925T patent/DE3683760D1/de not_active Expired - Lifetime
- 1986-03-21 AT AT86103925T patent/ATE72244T1/de not_active IP Right Cessation
-
1987
- 1987-02-11 ZA ZA870966A patent/ZA87966B/xx unknown
- 1987-02-12 AU AU68707/87A patent/AU586318B2/en not_active Expired
- 1987-02-13 CA CA000529737A patent/CA1240999A/en not_active Expired
- 1987-02-19 ID IDP16787A patent/ID810B/id unknown
- 1987-02-25 ES ES8700500A patent/ES2009486A6/es not_active Expired
- 1987-03-03 KR KR870001878A patent/KR870008875A/ko not_active Ceased
- 1987-03-03 US US07021161 patent/US4816455B1/en not_active Expired - Fee Related
- 1987-03-10 IL IL81841A patent/IL81841A/xx not_active IP Right Cessation
- 1987-03-16 AR AR87307027A patent/AR242384A1/es active
- 1987-03-16 GR GR870429A patent/GR870429B/el unknown
- 1987-03-16 JP JP62062343A patent/JPH0662615B2/ja not_active Expired - Fee Related
- 1987-03-17 HU HU871155A patent/HU200176B/hu unknown
- 1987-03-17 PT PT84496A patent/PT84496B/pt unknown
- 1987-03-17 NZ NZ219644A patent/NZ219644A/xx unknown
- 1987-03-18 IE IE70587A patent/IE59913B1/en not_active IP Right Cessation
- 1987-03-18 DK DK198701398A patent/DK173283B1/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US4816455A (en) | 1989-03-28 |
| IL81841A (en) | 1991-06-10 |
| ZA87966B (en) | 1987-08-04 |
| DK139887D0 (da) | 1987-03-18 |
| DK173283B1 (da) | 2000-06-13 |
| DK139887A (da) | 1987-09-22 |
| EP0237608B1 (de) | 1992-01-29 |
| PT84496A (de) | 1987-04-01 |
| ES2009486A6 (es) | 1989-10-01 |
| DE3683760D1 (de) | 1992-03-12 |
| IE870705L (en) | 1987-09-21 |
| HUT47101A (en) | 1989-01-30 |
| AR242384A1 (es) | 1993-03-31 |
| AU6870787A (en) | 1987-09-24 |
| IL81841A0 (en) | 1987-10-20 |
| HU200176B (en) | 1990-04-28 |
| NZ219644A (en) | 1989-04-26 |
| US4816455B1 (en) | 1992-11-24 |
| EP0237608A1 (de) | 1987-09-23 |
| JPS62226980A (ja) | 1987-10-05 |
| GR870429B (en) | 1987-07-13 |
| KR870008875A (ko) | 1987-10-21 |
| IE59913B1 (en) | 1994-04-20 |
| CA1240999A (en) | 1988-08-23 |
| AU586318B2 (en) | 1989-07-06 |
| JPH0662615B2 (ja) | 1994-08-17 |
| PT84496B (pt) | 1989-11-10 |
| ATE72244T1 (de) | 1992-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID810B (id) | KRISTAL BENTUK ε DARI 2-(4-(2-FUROIL)-(2-PIPERAZIN)-1-IL)-4-AMINO-6,7-DIMETOKSIQUINAZOLIN HIDROKLORIDA ANHIDRAT DAN PROSES UNTUK PEMBUATANNYA | |
| BR8701798A (pt) | Processo de formacao de uma estrutura trancada,e a estrutura trancada | |
| BR8803525A (pt) | Composicao,composto e processo para a producao de um composto | |
| IT8920124A0 (it) | Processo per la produzione di allumine boemitiche. | |
| BR8901552A (pt) | Artigo de ceramica aglomerada;estrutura de ceramica aglomerada;processo para a preparacao de uma estrutura de ceramica aglomerada | |
| BR8406993A (pt) | Processo para producao de microcapsulas | |
| BR8703345A (pt) | Processo para producao de cloro | |
| ES548568A0 (es) | Procedimiento para la produccion de material pigmentario. | |
| NO904453L (no) | Fremgangsmaate for fremstilling av bituminoese materialer. | |
| MX3681A (es) | Procedimiento para la produccion de gamma-carbolinas antipsicoticas y compuestos obtenidos. | |
| BR8906363A (pt) | Processo para producao de tricloromonosilano | |
| NO875134L (no) | Fremgangsmaate ved fremstilling av smoereolje. | |
| PT90971A (pt) | Processo para a preparacao de um material ceramico granular, poroso | |
| NO871265L (no) | Fremgangsmaate ved fremstilling av keramiske materialer. | |
| BR8701887A (pt) | Corpo refratario ignitado ligado por carbono,processo para producao de corpo refratario e corpo refratario | |
| BR8900171A (pt) | Processo para producao de catalisador zeolitico | |
| BR8702800A (pt) | Processo para fabricacao de acendedor,acendedor e pluraridade de acendedores | |
| FI872930A7 (fi) | Analogiamenetelmä ripulinvastaisten 4-(bentsoyyliamino)piperidiinibutaaniamidijohdannaisten valmistamiseksi | |
| BR8804414A (pt) | Processo para a producao de dos 2,2,4-monoesteres tri-substitui-insaturados | |
| BR8902740A (pt) | Processo para a preparacao de 2,2,4-trimetil-1,2-dihidroquinolina oligomera | |
| BR9002997A (pt) | Processo para producao de ester metilico de alfa-i-aspartil-i-fenilalanina cristalino,facilmente soluvel | |
| BR9006284A (pt) | Processo para producao de norcanfano dicarbonitrilas | |
| IT8920522A0 (it) | Procedimento per la produzione di vanadio areni. | |
| DK489687A (da) | Fremgangsmaade til gaering af stivelsesmateriale | |
| IT1230866B (it) | Procedimento per la produzione di coke. |